SCHEMBL1129586

SCHEMBL1129586

Oc1cc2ccc3cccc4c5ccccc5c(c1O)c2c34

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
CYP1A2 P05177 3/20 0.59
THRB P10828 2/20 0.59
HPGD P15428 2/20 0.59
HSD17B10 Q99714 2/20 0.59
ERBB2 P04626 1/20 0.53
FYN P06241 1/20 0.53
MAOA P21397 1/20 0.53
ACHE P22303 1/20 0.53
AHR P35869 1/20 0.53
TRPM4 Q8TD43 1/20 0.48
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
CDK2 P24941 3/20 0.44
KDM4E B2RXH2 2/20 0.44
POLB P06746 2/20 0.44
GAA P10253 2/20 0.44
MAPT P10636 2/20 0.44
INPPL1 O15357 1/20 0.44
NSD2 O96028 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9622094 0.89 ALDH1A1 (0.47) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL31017587 0.85 ALDH1A1 (0.49) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL3798632 0.80 CYP1A2 (0.70) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL2365624 0.80 ALDH1A1 (0.40) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL864719 0.79 CYP1A2 (0.55) ALDH1A1CYP1A2THRBHPGDHSD17B10
Pyrene SCHEMBL28151585 0.79 CYP1A2 (0.53) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL29831525 0.79 CYP1A2 (0.53) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL1229467 0.79 CYP1A2 (0.53) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL2047161 0.78 CYP1A2 (0.57) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL4847401 0.78 ALDH1A1 (0.73) ALDH1A1CYP1A2THRBHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118749699-A Non-tobacco leaf traditional Chinese medicine cigarette substitute formula product and preparation method and application thereof 江西新郎中养生有限公司 2024-10-11 CN disclosed
CN-111378084-B Polymer and hardmask composition and method of forming pattern 三星SDI株式会社 2023-08-08 CN disclosed
EP-2283112-B1 COMPOSITIONS COMPRISING PRFA*MUTANT LISTERIA AND METHODS OF USE THEREOF ADURO BIOTECH (US) 2016-10-12 EP disclosed
US-20110287055-A1 COMPOSITIONS COMPRISING PRFA* MUTANT LISTERIA AND MEHTODS OF USE THEREOF ADURO BIOTECH (US) 2011-11-24 US disclosed
US-7927606-B2 Free-living microbes are provided in which the nucleic acid has been modified so that the microbe is attenuated for proliferation and/or which comprise genetic mutations that attenuate the ability of the microbe to repair its nucleic acid. Methods using the modified microbes for the activation antigens ADURO BIOTECH (US) 2011-04-19 US disclosed
EP-2283112-A1 COMPOSITIONS COMPRISING PRFA*MUTANT LISTERIA AND METHODS OF USE THEREOF Aduro Biotech (US) 2011-02-16 EP disclosed
US-7833775-B2 Modified free-living microbes, vaccine compositions and methods of use thereof ADURO BIOTECH (US) 2010-11-16 US disclosed
US-7695725-B2 Modified free-living microbes, vaccine compositions and methods of use thereof ADURO BIOTECH (US) 2010-04-13 US disclosed
US-20100068230-A1 MODIFIED FREE-LIVING MICROBES, VACCINE COMPOSITIONS AND METHODS OF USE THEREOF CHINOOK THERAPEUTICS, INC. 2010-03-18 US disclosed
WO-2009143085-A1 COMPOSITIONS COMPRISING PRFA*MUTANT LISTERIA AND METHODS OF USE THEREOF ANZA THERAPEUTICS, INC. (US) 2009-11-26 WO disclosed
EP-0804074-A1 TREATING RED BLOOD CELL SOLUTIONS WITH ANTI-VIRAL AGENTS Cerus Corporation (US) 1997-11-05 EP disclosed
EP-0773716-A1 TREATING RED BLOOD CELL SOLUTIONS WITH ANTI-VIRAL AGENTS Cerus Corporation (US) 1997-05-21 EP disclosed
WO-1996039818-A1 TREATING RED BLOOD CELL SOLUTIONS WITH ANTI-VIRAL AGENTS CERUS CORPORATION (US) 1996-12-19 WO disclosed
US-5559250-A 5-/N,N-BIS/2-CHLOROETHYL/AMINO/METHYL-8-METHOXYPSORALEN STERITECH, INC. (US) 1996-09-24 US disclosed
WO-1996014737-A1 TREATING RED BLOOD CELL SOLUTIONS WITH ANTI-VIRAL AGENTS CERUS CORPORATION (US) 1996-05-23 WO disclosed
WO-1993010266-A1 DEVICE AND METHOD FOR DETECTION OF COMPOUNDS WHICH INTERCALATE WITH NUCLEIC ACIDS THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) 1993-05-27 WO disclosed
US-4959309-A Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays MOLECULAR DIAGNOSTICS, INC. (US) 1990-09-25 US disclosed
EP-0187332-B1 PHOTOCHEMICAL METHOD OF LABELLING NUCLEIC ACIDS FOR DETECTION IN HYBRIDIZATION ASSAYS MOLECULAR DIAGNOSTICS, INC. (US) 1989-02-01 EP disclosed
US-4794073-A Detection of nucleic acid hybrids by prolonged chemiluminescence MOLECULAR DIAGNOSTICS, INC. (US) 1988-12-27 US disclosed
US-4563417-A MEDICAL DIAGNOSIS MILES LABORATORIES, INC. (US) 1986-01-07 US disclosed